BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Biodefense
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20190310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20191103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20200308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20201101T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20210314T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20211107T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200924T090000
DTEND;TZID=America/New_York:20200924T124500
DTSTAMP:20200922T011659Z
CREATED:20200922T010030Z
LAST-MODIFIED:20200922T011659Z
UID:47128-1600938000-1600951500@globalbiodefense.com
SUMMARY:The Biological Event Horizon: No Return or Total Resilience
DESCRIPTION:A virtual meeting of the Bipartisan Commission on Biodefense will be held on Sep. 24 entitled\, “The Biological Event Horizon: No Return or Total Resilience“. \nThe ongoing novel coronavirus 2019 (COVID-19) pandemic is revealing major gaps in national readiness to prepare for\, respond to\, and recover from biological threats. Decision makers must consider enhancements to policies and programs to better defend against the next biological threat as the Nation continues to respond to the crisis. COVID-19 will not be the last biological threat we face and it likely will not be the worst as the risk of natural and human-generated threats continues to increase with time. \nAt this meeting\, the Commission intends to address these emerging biological threats and innovative science and technology solutions to address them. \nSpeakers include: \n\nJaime Yassif\, PhD: Senior Fellow\, Global Biological Policy and Programs\, Nuclear Threat Initiative\nSohini Ramachandran\, PhD: Associate Professor of Biology\, Director of Graduate Studies for the Center for Computational Molecular Biology\, Associate Professor of Computer Science\, Brown University\nNita Madhav\, MSPH\, Chief Executive Officer\, President\, and Board Member\, Metabiota\nRepresentative Susan Brooks (R-IN):  Member\, Subcommittee on Health\, Committee on Energy and Commerce\, U.S. House of Representatives\nRepresentative Diana DeGette (D-CO): Chair\, Subcommittee on Oversight and Investigation\, Committee on Energy and Commerce\, U.S. House of Representatives\nKavita M. Berger\, PhD: Director\, Board on Life Sciences\, National Academies of Sciences\nLuciana Borio\, MD: Vice President\, Technical Staff\, In-Q-Tel; Former Director for Medical and Biodefense Preparedness\, National Security Council; Former Assistant Commissioner for Counterterrorism Policy and Director\, Office of Counterterrorism and Emerging Threats\, Office of the Chief Scientist\, FDA; and Former Senior Medical Advisor\, Office of the ASPR\, DHHS\n\nPlease visit the Bipartisan Commission on Biodefense website for more information. \nGlobal Biodefense is not affiliated with the Bipartisan Commission on Biodefense and is providing this listing as a courtesy to the community.
URL:https://globalbiodefense.com/event/the-biological-event-horizon-no-return-or-total-resilience/
CATEGORIES:Policy-Legislative,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200923T130000
DTEND;TZID=America/New_York:20200923T140000
DTSTAMP:20200920T191330Z
CREATED:20200920T191330Z
LAST-MODIFIED:20200920T191330Z
UID:47120-1600866000-1600869600@globalbiodefense.com
SUMMARY:The Effects of COVID-19 on Latin America and the Economic Outlook
DESCRIPTION:Please join the CSIS Americas Program and the CSIS Economics Program for a discussion on how the Covid-19 pandemic is affecting the outlook in Latin America. The ongoing surge in Covid-19 cases across the region raises questions about the timing of recovery\, adequacy of macroeconomic responses\, and the role of private and official sectors in responding to the unprecedented health and economic crises. This event will explore these issues\, as well as sector-specific outlooks in the wake of the pandemic\, and the outlook for sovereign and corporate debt. \nFeaturing a discussion with Geoffrey Okamoto\, Deputy First Managing Director\, International Monetary Fund. \nFollowed by a panel discussion: \n\nChris Campbell\, Chief Strategist\, Duff & Phelps Institute\nKevin Gallagher\, Professor of Global Development Policy\, Boston University\, and Director of the Global Development Policy Center\nSamar Maziad\, Vice President and Senior Analyst\, Sovereign\, Moody’s Investors Service\n\nModerated by Stephanie Segal\, Senior Fellow\, Economics Program\, CSIS \nThis event is made possible thanks to the generous support of the Duff & Phelps Institute. \nFEATURING\n\n\n\nGeoffrey Okamoto\nFirst Deputy Managing Director\, International Monetary Fund\n\n\n\n\n\nSamar Maziad\nVice President and Senior Analyst\, Sovereign\, Moody’s Investors Service\n\n\n\n\n\nKevin Gallagher\nProfessor of Global Development Policy\, Boston University\, and Director of the Global Development Policy Center\n\n\n\n\n\nChristopher Campbell\nChief Strategist\, Duff & Phelps Institute
URL:https://globalbiodefense.com/event/the-effects-of-covid-19-on-latin-america-and-the-economic-outlook/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200923T090000
DTEND;TZID=America/New_York:20200923T160000
DTSTAMP:20200922T212137Z
CREATED:20200822T211622Z
LAST-MODIFIED:20200922T212137Z
UID:47153-1600851600-1600876800@globalbiodefense.com
SUMMARY:Leveraging Data Science Approaches to Address Environmental Health Challenges in Africa
DESCRIPTION:Environmental Health challenges in Africa are complex\, involving a broad range of exposures\, including ambient and indoor air pollution\, electronic waste\, heavy metals\, pesticides\, vector-borne pathogens\, and climate change\, and a large proportion of the disease burden in Africa is linked to environmental factors. This session will explore unique aspects and analytic challenges of the various types of environmental health data and will highlight recent data science approaches to characterizing hazardous exposures on the African continent\, connecting environmental exposures to health outcomes\, and reducing the risk of disease connected to the environment. \nModerator:\nGwen Collman\, Acting Deputy Director\, Associate Director for Extramural Research\, National Institute of Environmental Health Sciences \nPanelists:\nKiros Berhane\, Professor and Chair\, Department of Biostatistics\, Mailman School of Public Health\, Columbia University \nCaradee Wright\, Senior Specialist Scientist\, Environment and Health Research Unit\, South African Medical Research Council \nEngineer Bainomugisha\, Associate Professor and Chair\, Department of Computer Science\, School of Computing & IT\, Makerere University \nTo participate in the discussion and session\, you must register for the DS-I Africa Virtual Forum in advance. All content will also be recorded and posted on this website after each event.
URL:https://globalbiodefense.com/event/leveraging-data-science-approaches-to-address-environmental-health-challenges-in-africa/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200727
DTEND;VALUE=DATE:20200731
DTSTAMP:20191225T203815Z
CREATED:20191225T203815Z
LAST-MODIFIED:20191225T203815Z
UID:35853-1595808000-1596153599@globalbiodefense.com
SUMMARY:Achieving Data Quality and Integrity in Clinical Trials Involving High-Consequence Pathogens
DESCRIPTION:The FDA and the University of Texas Medical Branch\, Galveston National Laboratory (UTMB) are sponsoring an annual training course 27-30 July 2020 on how to meet good laboratory practice (GLP) requirements in biosafety level (BSL)-4 facilities. \nThe event will be hosted at the National Ebola Training and Education Center in Omaha\, Nebraska. \nThis  course offers a unique opportunity for the regulatory and scientific communities to discuss complex issues in an interactive environment and identify and share best practices for ensuring nonclinical data quality and integrity in BSL-4 facilities. \nPurpose of course\nThe purpose of this unique educational course is to provide a learning environment that: \n\nPromotes collaboration\nProvides tools for conducting clinical studies\nEnhances mutual understanding of clinical\, scientific\, and regulatory complexities\, and\nPromotes the data quality and integrity derived from these regulated studies.\n\nA heightened awareness of the complexities and uniqueness of high- and maximum-containment environments for high-consequence pathogens is the first step in initiating a dialog to find solutions for the planning and execution of studies where data generated will be used to support a regulatory decision. The result is a better-prepared cohesive community of clinical\, scientific\, and regulatory experts mutually engaged in\, and committed to\, the development\, research\, and approval of medical countermeasures for high-consequence pathogens. \nProfessionals who have experience with high-consequence pathogen clinical trials are encouraged to register\, including: \n\nPhysicians\nScientists\nPrincipal investigators\nPhysician assistants\nNurses and nurse practitioners\nPharmacists\nClinical laboratorians\nClinical research staff and clinical monitors\nRegulators and regulatory reviewers\nPolicy-makers\nIRB professionals\nIndustry sponsors\n\nCourse objectives and curriculum\nObjectives\n\nFormulate solutions to regulatory\, operational\, and cultural challenges for the conduct of clinical trials of medical countermeasures for high-consequence pathogens\nIdentify and mitigate risks to data quality and integrity\nResolve complexities of performing clinical trials in biocontainment / barrier nursing environment under good clinical practices (GCPs)\nGain experience conducting clinical research tasks in a mock biocontainment environment while wearing high-level personal protective equipment (PPE)\n\nCourse curriculum\n\nAddressing cultural and language barriers\nEthical considerations for placebo-controlled studies\nRegulatory expectations\nStudy monitoring\nBarrier nursing challenges\nSample integrity\nProtocol development\nOperationalizing a protocol\nProtocol driven data collection vs. clinical data\nGood documentation practices\nReporting adverse events\nInternational issues\nStakeholder roles and responsibilities\n\nBenefits of attending\n\nAttend this free course and earn continuing education (CE) credits.\nLearn from world-renowned faculty members and subject matter experts.\nApply best practices for clinical trials during an outbreak involving high-consequence pathogens.\nRecognize and prevent potential risks to data quality and integrity.\nEnhance cultural awareness and diversity involving clinical trials in geographic locations where outbreaks caused by high-consequence pathogens are frequent.\n\nAttendees will also learn from integrated scenarios\, case studies based on real-life experiences\, and expert panels\, along with lectures from experts from FDA\, the National Institutes of Health\, the NETEC\, and clinical biocontainment units (BCUs). \nPlease visit the FDA website Achieving Data Quality and Integrity in Clinical Trials Involving High-Consequence Pathogens for more information and UTMB’s Registration Page. \n 
URL:https://globalbiodefense.com/event/achieving-data-quality-and-integrity-in-clinical-trials-involving-high-consequence-pathogens/
LOCATION:National Ebola Training and Education Center (NETEC)\, Omaha\, NE\, United States
CATEGORIES:Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200722T140000
DTEND;TZID=America/New_York:20200722T163000
DTSTAMP:20200709T212451Z
CREATED:20200709T212352Z
LAST-MODIFIED:20200709T212451Z
UID:46694-1595426400-1595435400@globalbiodefense.com
SUMMARY:Next Steps for Functional Genomics: A Workshop and Proceedings Release
DESCRIPTION:The National Academies of Sciences\, Engineering\, and Medicine (NASEM) will convene in a virtual meeting open to the public on July 22\, 2020 to unveil and summarize written proceedings a previous workshop on the future of functional genomics research. \nDuring this proceedings release\, you will have the opportunity to hear from Gene Robinson and Lauren O’Connell\, who were members of the workshop planning committee\, about important insights that were gained over the course of the workshop. \nThe workshop itself was held in February in Washington\, DC\, and included speakers\, panels\, and interactive sessions\, that explored the scientific advancements needed to utilize functional genomics to solve societal problems in areas such as conservation\, evolutionary studies\, agriculture\, energy\, defense\, human health\, and other sectors. \nOver the course of the workshop speakers and participants looked to address the current state of the science\, what lessons have been learned thus far\, what current impediments there are to further progress\, and areas where additional investments could help move the field forward. Importantly\, the workshop served as a platform for discussion within the functional genomics community. \nPlease visit the NASEM website to register. \n 
URL:https://globalbiodefense.com/event/next-steps-for-functional-genomics-a-workshop-and-proceedings-release/
CATEGORIES:Conference,Webinar-Webcast,Workshop
LOCATION:https://nasem.zoom.us/webinar/register/WN_HRB5dQrxRaq16gYVKyZnmA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200721T100000
DTEND;TZID=America/New_York:20200721T150000
DTSTAMP:20200709T183244Z
CREATED:20200709T183155Z
LAST-MODIFIED:20200709T183244Z
UID:46618-1595325600-1595343600@globalbiodefense.com
SUMMARY:COVID Complexities: Converging Threats\, Fractured Resources
DESCRIPTION:A virtual meeting of the Bipartisan Commission on Biodefense will be held on July 21\, 2020 to discuss “COVID Complexities: Converging Threats\, Fractured Resources”. \nThe ongoing novel coronavirus 2019 (COVID-19) pandemic has taken the lives of more than 100\,000 Americans and damaged the Nation’s economy. As the country reopens\, the disease threatens the public\, now and into the foreseeable future. Federal support for state\, local\, tribal and territorial preparedness and biosurveillance will be crucial to addressing further spread of COVID-19. The Commission intends to address national policy and resource needs for response to and recovery from this crisis. \nSpeakers include: \nJared Moskowitz – Director\, Florida Division of Emergency Management \nAlexis Madrigal – Co-Founder\, The COVID Tracking Project\, and Staff Writer\, The Atlantic \nDavid Mitchell – President\, International Association of Emergency Medical Services Chiefs \nSpeakers will discuss the potential for compoundment of the biological threat\, disease-tracking needs\, hospital preparedness\, and emergency management challenges. \nPlease visit the Bipartisan Commission on Biodefense website to register for this free event.
URL:https://globalbiodefense.com/event/covid-complexities-converging-threats-fractured-resources/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://globalbiodefense.com/event/covid-complexities-converging-threats-fractured-resources/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200702T110000
DTEND;TZID=America/New_York:20200702T123000
DTSTAMP:20200624T194613Z
CREATED:20200624T194613Z
LAST-MODIFIED:20200624T194613Z
UID:46421-1593687600-1593693000@globalbiodefense.com
SUMMARY:The U.S. Chemical Supply Chain: Vulnerabilities Highlighted by COVID-19
DESCRIPTION:The National Academies Board on Chemical Sciences and Technology will convene a webcast meeting on July 2\, 2020 to discuss The U.S. Chemical Supply Chain: Vulnerabilities Highlighted by COVID-19. \nThroughout the COVID-19 pandemic\, the chemical industry in the United States has maintained operating status and continues to be at the forefront of worker safety. Despite these achievements\, the pandemic exposed some of the vulnerabilities in the chemical industry’s supply chain. \nWith an increased demand for chemical products\, such as isopropyl alcohol for the production of hand sanitizer\, the United States has seen firsthand the inflexibility of the supply chain to increase or alter production. The “just-in-time” manufacturing approach that many companies previously adopted to maximize efficiency and lower costs has now presented the industry with production challenges and raises the question of how demand can be met if a disruption to the supply chain occurs. Also of note are the specialty chemical and pharmaceutical industries\, which are increasingly vulnerable as they have outsourced many of their operations overseas. \nIn the event of a global disruption or a localized disruption unique to the point of origin\, the United States risks not being able to obtain the products it critically needs—such as personal protective equipment\, medications\, and medical equipment—as has occurred in the case of COVID-19. \n This webinar\, hosted by the Chemical Sciences Roundtable\, will aim to highlight these two vulnerabilities in the supply chain: the inelasticity of the chemical supply chain and the risks posed by the overseas manufacturing of specialty and pharmaceutical chemicals. \nSpeakers include: \n\nDr. David Bem\, VP of Science and Technology and CTO at PPG Industries\, Inc.\nDr. T. Kevin Swift\, Chief Economist at American Chemistry Council\nDr. Ron Piervincenzi\, CEO of United States Pharmacopeia\n\nA recording of the webinar will be made available after the event. Click here to register for this event.
URL:https://globalbiodefense.com/event/the-u-s-chemical-supply-chain-vulnerabilities-highlighted-by-covid-19/
LOCATION:Virtual-Webcast
CATEGORIES:Conference,Webinar-Webcast,Workshop
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/06/chemical-sciences-roundtable-nasem-covid-19.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200702
DTEND;VALUE=DATE:20200703
DTSTAMP:20200211T231336Z
CREATED:20200211T230408Z
LAST-MODIFIED:20200211T231336Z
UID:39295-1593648000-1593734399@globalbiodefense.com
SUMMARY:Deadline for NIBIB Technology Accelerator Challenge: Handheld Diagnostics
DESCRIPTION:NIH Technology Accelerator Challenge: Non-invasive Diagnostic Technologies for Global Health \nThis challenge seeks designs for non-invasive technology platforms to diagnose sickle cell disease\, malaria\, and anemia. While not constrained to any specific technology\, the inspiration for this challenge comes from the widespread availability of mobile phones and the potential for mobile phone-linked sensor technologies to non-invasively detect changes in the blood and vasculature associated with these treatable diseases. \nKey Dates\nRelease Date: January 31\, 2020\nEstimated Competition Opening Date: March 2\, 2020\nEstimated Competition Closing Date: July 2\, 2020 \nRead more about this opportunity in Funding News. \n  \nGlobal Biodefense provides this information as a courtesy. Information is subject to change. Please check the funding opportunity sponsor website to verify the most current status.
URL:https://globalbiodefense.com/event/deadline-for-nibib-technology-accelerator-challenge-handheld-diagnostics/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200629T133000
DTEND;TZID=America/New_York:20200629T143000
DTSTAMP:20200624T201831Z
CREATED:20200624T201628Z
LAST-MODIFIED:20200624T201831Z
UID:46424-1593437400-1593441000@globalbiodefense.com
SUMMARY:COVID-19\, Systemic Racism\, and the Responses of HBCUs: A Virtual Town Hall Discussion
DESCRIPTION:The National Academies of Sciences\, Engineering and Medicine Board on Higher Education and Workforce will host a virtual town hall on Jun 29\, 2020 to discuss COVID-19\, Systemic Racism\, and the Responses of HBCUs. \nHistorically Black Colleges and Universities (HBCUs) are among the nation’s most vital and vibrant institutions\, serving the educational needs of hundreds of thousands of students\, advancing the full spectrum of human knowledge\, and invigorating the cultural\, social\, and economic horizons of the regions they serve. And today\, these universities are at the forefront of the fight against COVID-19\, researching treatments\, keeping their states and communities informed\, and treating patients at academic medical centers.  They are also at the forefront of the nation’s struggles against institutionalized discrimination\, systemic inequality\, and anti-Black racism that are being brought to bear every day in the forms of demonstrations and advocacy in most U.S. communities. \nHow have HBCUs responded to the COVID-19 pandemic and to the recent events surrounding the murder of George Floyd?  As HBCU presidents look toward resuming in-person classes in the fall\, what have they learned from the COVID-19 crisis\, how will their institutions evolve as a result\, and what might that mean for the future of HBCUs in America?  How will HBCUs adapt to the serious financial challenges likely to arise in states and the nation in the months ahead as a consequence of COVID-19? What are HBCU campus leaders doing in preparation for a stronger and higher-profile role in terms of advocacy and leadership in directly addressing anti-Black racism in this country? \nPlease join the presidents of three of the nation’s premier HBCUs as they discuss COVID-19 and issues of racial injustice. This event is hosted by the National Academies’ Board on Higher Education and Workforce and Issues in Science and Technology and sponsored by the Kresge Foundation and the U.S. Department of Defense HBCU/MI Program. \nSpeakers include: \n\nMakola M. Abdullah\, President of Virginia State University\nMary Schmidt Campbell\, President of Spelman College\nC. Reynold Verret\, President of Xavier University of Louisiana\n\nModerated by Gilda Barabino\, President-elect of Olin College of Engineering \nPlease contact John Veras (jveras@nas.edu) for questions.
URL:https://globalbiodefense.com/event/covid-19-systemic-racism-and-the-responses-of-hbcus-a-virtual-town-hall-discussion/
LOCATION:Virtual-Webcast
CATEGORIES:Conference,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/06/covid-19-systemic-racism-hbcu-black-colleges-nasem.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200628
DTEND;VALUE=DATE:20200703
DTSTAMP:20200430T163909Z
CREATED:20191220T164248Z
LAST-MODIFIED:20200430T163909Z
UID:35676-1593302400-1593734399@globalbiodefense.com
SUMMARY:[CANCELLED] CSTE Annual Conference 2020
DESCRIPTION:For attendees that have already registered for the 2020 Annual Conference and booked hotel accommodations through CSTE’s official housing provider\, Orchid Events\, no action is required on your part. Your meeting registration will automatically be cancelled\, and a full refund will be issued via your original payment method within 30 days.  \nThe Council of State and Territorial Epidemiologists will host the CSTE Annual Conference from June 28 – July 2\, 2020 in Seattle\, Washington. \nThis event is attended by more than 1\,700 public health epidemiologists from across the country and will include workshops\, plenary sessions with leaders in the field of public health\, oral breakout sessions\, roundtable discussions\, and poster presentations. \nConference attendees meet and share their expertise in surveillance and epidemiology as well as best practices in a broad range of areas including informatics\, infectious diseases\, substance use\, immunizations\, environmental health\, occupational health\, chronic disease\, injury control\, and maternal and child health. \nPlease visit the CSTE 2020 website for more information and to register.
URL:https://globalbiodefense.com/event/cste-annual-conference-2020/
LOCATION:Seattle\, Seattle\, WA\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200618
DTEND;VALUE=DATE:20200623
DTSTAMP:20200430T162843Z
CREATED:20190907T224306Z
LAST-MODIFIED:20200430T162843Z
UID:30282-1592438400-1592870399@globalbiodefense.com
SUMMARY:[CANCELLED] ASM Microbe 2020
DESCRIPTION:Update from ASM on March 30\, 2020\nAfter much thoughtful discussion\, the American Society for Microbiology Board of Directors has made the difficult decision to cancel ASM Microbe 2020\, scheduled for June 18-22\, 2020\, in Chicago\, Ill. \nASM Microbe 2020 will be held 18-22 June 2020 in Chicago\, Illinois. \nSave the date! More details will be posted as the event draws closer. \nASM Microbe 2020\, sponsored by the American Society for Microbiology\, showcases the best microbial sciences in the world\, and provides a one-of-a-kind forum to explore the complete spectrum of microbiology from basic science to translation and application. \nThe event allows scientists to showcase research to the world of microbial scientists and delve into scientific interests and specialties with sessions in core specialty tracks. \nLearn more: http://bit.ly/ASMmicrobe2020 \n 
URL:https://globalbiodefense.com/event/asm-microbe-2020/
LOCATION:TBA – Chicago\, Chicago\, IL\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200617
DTEND;VALUE=DATE:20200618
DTSTAMP:20200520T204211Z
CREATED:20200520T204211Z
LAST-MODIFIED:20200520T204211Z
UID:45697-1592352000-1592438399@globalbiodefense.com
SUMMARY:Biotechnology for Materiel and Defense Symposium
DESCRIPTION:The Biotechnology for Material and Defense Symposium virtual event will be hosted by the National Defense Industrial Association on June 17\, 2020. \nRecent advances in Synthetic Biology\, Biotechnology\, and their supporting infrastructure—biodesign\, automation\, artificial intelligence\, and data analytics—are affording transformational impacts beyond traditional opportunity spaces to produce natural polymers and composites\, synthesize new molecules for coatings and resins\, and ‘grow’ structural materials such as leathers and foams. \nFuture capabilities such as biosensors and nano-structure material production are on the cusp of implementation. The far future promises the ability for in-situ production\, self-healing\, and more. This ability to harness nature’s processes to produce molecules and materials in a sustainable way has the potential to not only have a positive impact on the environment and domestic manufacturing but also radically change how we design\, build\, maintain\, and support our troops. \nPlease visit the NDIA’s Biotechnology for Material and Defense Symposium website for more information and to register. \n 
URL:https://globalbiodefense.com/event/biotechnology-for-materiel-and-defense-symposium/
LOCATION:Virtual-Webcast
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200616T100000
DTEND;TZID=America/New_York:20200616T120000
DTSTAMP:20200709T194433Z
CREATED:20200609T193108Z
LAST-MODIFIED:20200709T194433Z
UID:46622-1592301600-1592308800@globalbiodefense.com
SUMMARY:COVID-19 Effects on the Food and Agricultural System
DESCRIPTION:The Board on Agriculture and Natural Resources (BANR) of the National Academies of Science\, Engineering\, and Medicine hosted a webinar on Friday\, June 19 from 10:00 – Noon EDT with a virtual panel discussion on COVID 19 effects on the food and agricultural system\, which has experienced severe stress from a combination of factors. Workers’ health has been placed at risk\, producers have lost markets\, and animals and crops have been sacrificed. Meanwhile\, food prices are on the rise and unemployed Americans have turned in greater numbers than ever to overstressed food banks. A panel of distinguished participants in the food and agricultural system offered perspectives on the impacts and how we can learn from them. \nInvited perspectives include: \n\nA.G. Kawamura\, Owner\, Orange County Produce\, and former Secretary of the California Department of Food and Agriculture (2003-2010)\nTom Vilsack\, President and CEO\, U.S. Dairy Export Council\, and former United States Secretary of Agriculture (2009 – 2017)\n\nThe session was moderated by BANR Chairman\, Chuck Rice (Kansas State University). Members of the Board on Agriculture and Natural Resources lead with questions to the presenters\, and the public was able to type in questions to be asked by the moderator. \nVisit NASEM’s website to register.
URL:https://globalbiodefense.com/event/covid-19-effects-on-the-food-and-agricultural-system/
CATEGORIES:Conference,Webinar-Webcast,Workshop
LOCATION:https://vimeo.com/430827259
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200609
DTEND;VALUE=DATE:20200611
DTSTAMP:20200609T170801Z
CREATED:20200527T162939Z
LAST-MODIFIED:20200609T170801Z
UID:46303-1591660800-1591833599@globalbiodefense.com
SUMMARY:APG Advance Planning Briefing to Industry 2020
DESCRIPTION:The Aberdeen Proving Ground (APG) Advance Planning Briefing to Industry (APBI) and Technological Expo\, will be held virtually on 9-10 June 2020\, in lieu of being hosted live at APG\, MD. \nThe goal of the APG APBI is to provide industry with networking opportunities for both large and small businesses. The APBI will describe potential future contracting opportunities for mission areas that focus on: \n\nChemical and Biological Defense\nCommand\, Control\, Communications\, Computers\, Cyber\, Intelligence\, Surveillance\, and Reconnaissance\nResearch and Development\nTest and Evaluation\nAPG Garrison\n\nThe APG APBI will identify potential contracting opportunities that are aligned with the roadmaps of each respective organization\, specifically focusing on Fiscal Years 2021–2022. The Government will not hear formal bids from industry\, as the purpose of the APBI is for the Government to brief upcoming opportunities to industry to help it better understand Army capability requirements and shape its internal development efforts. \nDAY ONE \n0730–0830 Microsoft Teams Setup\n0830–0845 Welcome Remarks by MG Kilgo\n0850–0950 Army Contracting Command-Aberdeen Proving Ground\n0955–1125 Army Contracting Command-Aberdeen Proving Ground: Role of Division Chiefs\n1130–1245 Communications-Electronics Command Defense Logistics Agency-Aberdeen Proving Ground\n1330–1445 Program Executive Office Command Control Communications-Tactical & Network Cross-Functional Team\n1450–1520 Joint Program Executive Office for Chemical\, Biological\, Radiological and Nuclear Defense  Click to download slides for JPEO-CBRND presentation \nDAY TWO \n0730–0830 Microsoft Teams Setup\n0830–0930 Program Executive Office for Intelligence\, Electronic Warfare & Sensors\n0935–1005 Program Executive Office for Intelligence\, Electronic Warfare & Sensors: C5 OTA Consortium Overview\n1010–1040 Program Executive Office for Intelligence\, Electronic Warfare & Sensors: Multi-Domain Sensing System Contract Strategy Overview\n1045–1115 Program Executive Office for Intelligence\, Electronic Warfare & Sensors: PM\, Electronic Warfare & Cyber 21 Strategic Planning Guidance\n1120–1150 Combat Capabilities Development Command\n1155–1225 Combat Capabilities Development Command-CMOSS\n1230–1300 Army Test and Evaulation Command\n1305–1335 A Message from the Office of Small Business Programs\n1340–1410 APG Garrison\n1415–1445 Closing Remarks by MG Kilgo \nThe APG APBI will be unclassified and open to all interested contractors\, large and small businesses\, and academia\, as well as other Government stakeholders. There is no registration required for this event. \nIf you or your company has already purchased a ticket for APBI or reserved a table for the 2020 Team APG Tech Expo\, please contact MissionTix directly for a refund. MissionTix contact information is: 888-996-4774 or help@missiontix.com.
URL:https://globalbiodefense.com/event/apg-advance-planning-briefing-to-industry-2020/
LOCATION:Virtual-Webcast
CATEGORIES:Conference,Government Hosted,Industry Day,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/06/apg-abpi-cbrne-2020.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20200604T140000
DTEND;TZID=America/Los_Angeles:20200604T160000
DTSTAMP:20200605T214039Z
CREATED:20200527T213856Z
LAST-MODIFIED:20200605T214039Z
UID:46255-1591279200-1591286400@globalbiodefense.com
SUMMARY:COVID-19 Testing and Testing Related Activities with CDC Experts
DESCRIPTION:On Thursday June 4th at 2:00 pm\, the National Association of Rural Health Clinics will be hosting a webinar with experts from the CDC who will be talking about COVID-19 testing and testing related activities. \n\nExperts will talk about the actual testing process\, best practices for collecting samples\, how to align with state officials for more state-specific information and much more. There will also be ample time built into the session for questions from the audience. This webinar is free and open to all. Please feel free to share this information with others whom you think might benefit from participating in this webinar.
URL:https://globalbiodefense.com/event/covid-19-testing-and-testing-related-activities-with-cdc-experts/
LOCATION:Virtual-Webcast
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200528
DTEND;VALUE=DATE:20200530
DTSTAMP:20200206T193045Z
CREATED:20200206T192643Z
LAST-MODIFIED:20200206T193045Z
UID:38922-1590624000-1590796799@globalbiodefense.com
SUMMARY:The Critical Public Health Value of Vaccines in the Age of Pandemics - A Workshop
DESCRIPTION:The National Academies of Sciences\, Engineering\, and Medicine Board on Global Health will host a 1.5-day public workshop May 28-29 that will examine the current state of vaccine preventable diseases and the impact of vaccine access and hesitancy globally\, and the multidimensional drivers and impacts of declining vaccine confidence. \nThis workshop will explore health systems\, research opportunities\, communication strategies\, and policies that could be considered to address access\, perceptions\, attitudes\, and behaviors toward vaccination. \nSpecifically\, this workshop will feature invited presentations and discussions on the following topics: \n• The global impact of declining immunization rates on vaccine-preventable diseases from lack of access and confidence;\n• Trends and indicators to monitor attitudes surrounding vaccine safety and efficacy\, including a focus on regional and cultural differences;\n• The complex determinants of vaccination that hinder or promote vaccine uptake;\n• The role of health systems and professionals in improving access\, influencing vaccine behavior\, protecting at-risk communities from vaccine-preventable disease outbreaks\, and preserving and building confidence in immunization strategies and practices;\n• The role of media\, anti-vaccine networks\, and online misinformation in reinforcing anxieties about vaccine safety and drivers of vaccine hesitancy;\n• Strategies to enhance community-based approaches and community engagement efforts for improving access and reducing vaccine hesitancy;\n• Communication approaches that would help assuage anxieties about vaccine safety and strengthen public trust in science and health professionals;\n• The ethics and effectiveness of legislation that aim to address vaccine hesitancy; and\n• Potential priority actions as well as partnerships and collaborations among policy makers\, health professionals\, national and international health organizations\, parents\, and community groups to increase immunization access and vaccine confidence.
URL:https://globalbiodefense.com/event/the-critical-public-health-value-of-vaccines-in-the-age-of-pandemics-a-workshop/
CATEGORIES:Workshop
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20200520T110000
DTEND;TZID=America/Los_Angeles:20200520T123000
DTSTAMP:20200513T135220Z
CREATED:20200513T135220Z
LAST-MODIFIED:20200513T135220Z
UID:45402-1589972400-1589977800@globalbiodefense.com
SUMMARY:COVID-19 and the Impact on Communities of Color: Our Nation’s Inequities Exposed
DESCRIPTION:The webinar will highlight the disproportionate health and economic impacts the pandemic is having on communities of color and the short- and long-term efforts needed to advance equity in the response to and recovery from the COVID-19 pandemic and future public health emergencies. There will also be a focus on recent federal legislation and state actions in response to COVID-19.
URL:https://globalbiodefense.com/event/covid-19-and-the-impact-on-communities-of-color-our-nations-inequities-exposed/
LOCATION:Virtual-Webcast
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200503
DTEND;VALUE=DATE:20200507
DTSTAMP:20200430T163052Z
CREATED:20190907T221152Z
LAST-MODIFIED:20200430T163052Z
UID:30271-1588464000-1588809599@globalbiodefense.com
SUMMARY:[CANCELLED] ASM Clinical Virology Symposium 2020
DESCRIPTION:“After careful consideration\, ASM’s Clinical Virology Symposium will not be held May 3-6\, 2020. Based on the U.S. Centers for Disease Control and Prevention’s recent recommendation against holding gatherings with 50 or more people for the next eight weeks\, we believe this is the responsible decision and in the best interest of our community.” \nThe 2020 ASM Clinical Virology Symposium will be held May 3–6 in West Palm Beach\, Florida. \nSave the date! Agenda items will be updated as the meeting dates approach. \nThis annual conference covers the latest on microbiome-virome interactions\, RNA sequencing for viral diagnosis\, the challenges and opportunities for a universal influenza vaccine\, and more. \nWatch on demand these industry workshops from the 2019 ASM Clinical Virology Symposium: \n\nDetection of Influenza and Other Respiratory Viruses With The Panther Fusion® Assays\nKathleen Stellrecht; Albany Medical Center\nAddressing the Challenges in the Diagnosis of Lower Respiratory Tract Infections:  The BioFire FilmArray Pneumonia Panel​ ​\nChristine C. Ginocchio; bioMerieux/BioFire\nBioFire Pneumonia Panel: Preparation\, Validation\, and Go Live \nRaul Benavides; Baylor Univeristy Medical Center (Dallas)\nMultiCenter Clinical Trial Study of the Sentosa® SQ HIV Genotyping Assay – A Next Generation Sequencing Test \nBelinda Yen-Lieberman; Cleveland Clinic\nOur Validation Experience: Augusta HIV Map \nRavindra Kolhe; Medical College of Georgia Augusta University\nFilm Array Pneumonia Panel Finding the Best Fit \nSusan Whittier; Columbia University Irving Medical Center\nGetting It Fast vs Getting It Right: Clinician Perspective \nMadison Orsburn; Millard Henry Clinic\nPCR is Better Than RIDT. IDSA Says So – Laboratory Perspective\nGregory Berry; Northwell Health Labs and Long Island Jewish Medical Center\nLaboratory Diagnosis of Bordetella Infections: Rapid\, Direct Detection and Differentiation of B. Pertussis and B. Parapertussis \nJim Dunn; Texas Children’s Hospital\nRapid Detection of Varicella Zoster Virus Central Nervous System Infections\nPreeti Pancholi; The Ohio State University\n\nVisit the 2020 ASM Clinical Virology Symposium website for the latest information.
URL:https://globalbiodefense.com/event/asm-clinical-virology-symposium-2020/
LOCATION:West Palm Beach\, West Palm Beach\, FL\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200424
DTEND;VALUE=DATE:20200425
DTSTAMP:20200222T220028Z
CREATED:20200222T215710Z
LAST-MODIFIED:20200222T220028Z
UID:40125-1587686400-1587772799@globalbiodefense.com
SUMMARY:Quickfire Challenge Applications Due: JLABS Pediatric Influenza Innovations
DESCRIPTION:Innovators within the fields of pediatric oncology\, pediatric surgery and influenza are invited to submit innovative ideas for a total of up to $150\,000 in grant funding; one year of residency at JLABS @ Washington\, DC with the use of a bench\, workstation\, and access to the JLABS @ Washington\, DC community; and mentorship from experts at the Johnson & Johnson Family of Companies. \nThe submission deadline is 24 April 2020. Please visit the JLABS website for more information.
URL:https://globalbiodefense.com/event/quickfire-challenge-applications-due-jlabs-pediatric-influenza-innovations/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200421T130000
DTEND;TZID=Europe/London:20200421T140000
DTSTAMP:20240623T192624Z
CREATED:20200406T161624Z
LAST-MODIFIED:20240623T192624Z
UID:42642-1587474000-1587477600@globalbiodefense.com
SUMMARY:DASA Biosensing Across Wide Areas Phase 2 Launch
DESCRIPTION:Join the Defence and Security Accelerator for a dial-in on 21 April 2020\, 1pm to 2pm. The competition team will provide a short briefing on the Biosensing Across Wide Areas Phase 2 competition followed by an open forum Q&A session. \nOne to Ones\nThere will be two opportunities for One to One dial-in sessions with the competition team: \n\nWednesday 21 April 2020 –  2.30pm to 4pm: Three slots available\nThursday 22 April 2020 – 1pm to 3pm: Four slots available\n\nThese pre-bookable 20 minute one to one slots will be with the competition team to discuss questions specific to your proposal. Slots are on a first come\, first serve basis. \nPlease note: \n\na separate link will be sent to you on your ticket confirmation to register for a one to one slot\ndetails of the dial in will be sent before the meeting commences\nif the event is oversubscribed\, we may place a limitation on the number of attendees from a single organisation\n\n// \nREAD MORE: UK Launches Wide-Area Biosensor Competition
URL:https://globalbiodefense.com/event/dasa-biosensing-across-wide-areas-phase-2-launch/
CATEGORIES:Conference,Industry Day,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/04/97aef6bbedcf01db65e877ee6755e43d.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200420
DTEND;VALUE=DATE:20200425
DTSTAMP:20200323T183614Z
CREATED:20191219T152600Z
LAST-MODIFIED:20200323T183614Z
UID:35622-1587340800-1587772799@globalbiodefense.com
SUMMARY:POSTPONED | NO NEW DATE - BSL-4 Training: Achieving Data Quality and Integrity in Maximum Containment Laboratories
DESCRIPTION:The FDA and the University of Texas Medical Branch\, Galveston National Laboratory (UTMB) will host this year’s annual training course on how to meet GLP requirements in BSL-4 facilities from April 20-24\, 2020 at the National Institutes of Health (NIH) in Bethesda\, Maryland. \nScientists working to develop Medical Countermeasures (MCMs) against several high-priority biological threat agents are at high risk of aerosol-transmitted laboratory infection and life-threatening disease\, as there are no vaccines or treatments for these agents. Accordingly\, much of the work to develop MCMs for these high-priority agents must be done in high and maximum biosafety level (BSL)-4 laboratories to prevent the agents from being released into the environment\, and to provide maximum safety for the scientists. \nThe unique challenges of BSL-4\nWhile necessary to ensure lab worker safety and prevent accidental release of dangerous pathogens\, BSL-4 environments pose unique challenges to developing MCMs. For example\, data generated to support a regulatory submission to FDA must be collected in accordance with quality systems\, like good laboratory practice (GLP) regulations\, to be useful and reliable\, and to facilitate FDA review to ensure safety and efficacy. \nHowever\, meeting data quality and integrity standards like GLP in a BSL-4 environment is challenging. Current practice is often inconsistent among laboratories due to technological infrastructure\, available internal standard operating procedures\, level of regulatory awareness\, and individual breadth of experience and training. And completing even routine lab tasks in a protective BSL-4 suit can be difficult—imagine\, for example\, trying to pick up a small item\, like a toothpick\, while wearing two pairs of thick gloves. \nTo help address the challenges associated with ensuring data quality and integrity in regulated studies conducted in BSL-4 laboratories to support MCM development\, FDA and the University of Texas Medical Branch\, Galveston National Laboratory (UTMB) collaborate to provide an annual training course on how to meet GLP requirements in BSL-4 facilities (“data quality course”). \n\nThis popular course offers a unique opportunity for the regulatory and scientific communities to discuss complex issues in an interactive environment and identify and share best practices for ensuring data quality and integrity in BSL-4 facilities. \n\nIn addition to UTMB and FDA\, other federal partners from the National Interagency Confederation for Biological Research (NICBR) provide support and resources for this course. These partners include: \n\nFrom the National Institutes of Health\n\nOffice of the Director\nNational Institute of Allergy and Infectious Diseases (NIAID)\nNational Cancer Institute (NCI)\n\n\nFrom the Department of Defense\n\nU.S. Army Medical Research and Materiel Command (USAMRMC)\n\n\n\n\nFrom the Department of Homeland Security\n\nNational Biodefense Analysis and Countermeasures Center (NBACC)\n\n\n\nHistory and new additions\nSince the data quality course began in 2013\, it has quickly reached capacity each year. In its first five years\, 269 participants completed the course. \nIn September 2017\, the FDA Medical Countermeasures Initiative (MCMi) renewed the grant  to continue the data quality course for an additional five years\, from 2018-2022. UTMB and FDA will also expand on-demand online offerings\, adding data quality-related good clinical practices (GCP) training and other courses to meet the needs of researchers responding to emerging infectious disease outbreaks. \nCourse description\nThe week-long\, data quality course is designed to help researchers who conduct studies intended to support approval under the Animal Rule\, which may be used to grant marketing approval of certain products when human challenge studies would not be ethical or feasible. \nThe course includes expert lectures and hands-on laboratory activities conducted in BSL-2 and BSL-4 training laboratories to emphasize the differences between biosafety levels\, and the complexity of conducting laboratory activities in a BSL-4 environment. An online training module on GLP regulations (21 CFR Part 58) is included as a course pre-requisite. For additional information\, visit the official UTMB course website \nTopics covered include: \n\nAnimal Rule regulations\, and clinical applications of Animal Rule studies\nAssay validation\nBSL-2/3/4 comparison\, with hands-on simulations\nBSL-4 equipment\, with hands-on work in a BSL-4 training lab\nDisease agent characterization\nGLP regulations\nGood documentation practices\nInstitutional Animal Care and Use Committee (IACUC) protocols\nTelemetry\nSupportive care\nSurrogate endpoints\nTesting facility management\nVeterinary pathology\nIntegration of quality assurance (QA) in BSL-4 studies\nAdvancement of MCMs on the international stage\n\nWho may attend?\nFDA welcomes participants from government\, industry\, and academia. We welcome international participation as well; attendees in previous years have included representatives from international public health agencies. Attendees typically include: \n\nPolicy-makers\nMCM product sponsors (industry)\nQuality assurance personnel\nRegulators\nReviewers\nScientists\nVeterinarians\n\nPre-requisites include GLP and IACUC training that are available to course attendees. \nCourse Cost and Availability\nThere are no registration fees for this FDA-sponsored course\, however\, seats are limited\, and course attendees are invited based upon diversity of roles\, responsibilities\, and organization. Interested participants will be placed on a waitlist once seats are filled. \nRELATED INFORMATION \n\nInformation about the course from UTMB\nSister course: Achieving Data Quality and Integrity in Clinical Trials Involving High-Consequence Pathogens\nPrevious course offerings\nView photos from the 2015 course on Flickr
URL:https://globalbiodefense.com/event/bsl-4-training-achieving-data-quality-and-integrity-in-maximum-containment-laboratories/
LOCATION:National Institutes of Health (NIH)\, Bethesda\, MD\, United States
CATEGORIES:Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200415T170000
DTEND;TZID=America/New_York:20200415T183000
DTSTAMP:20240623T192248Z
CREATED:20200414T182247Z
LAST-MODIFIED:20240623T192248Z
UID:43055-1586970000-1586975400@globalbiodefense.com
SUMMARY:APHA and National Academy of Medicine Webinar: Crisis Standards of Care During COVID-19
DESCRIPTION:Brought to you by the American Public Health Association and the National Academy of Medicine\, this webinar series is exploring the state of the science surrounding the current outbreak of COVID-19 in the United States and globally\, with a focus on the emerging evidence on how to best mitigate its impact. Hear from trusted experts in such fields as public health\, infectious disease\, risk communication\, and crisis standards of care. \nWebinar #4: Crisis Standards of Care During COVID-19\nWednesday\, April 15\, 5-6:30 p.m. ET \nThe fourth COVID-19 Conversations webinar will provide an overview of crisis standards of care during a pandemic\, challenges for adapting such standards to rapidly evolving clinical care guidelines\, practical considerations for state health departments and hospital systems\, and ethical considerations for decision-making while enacting crisis standards of care. \nThe expert panel for this webinar includes: \n\nJohn L. Hick\, MD\, is a faculty emergency physician at Hennepin County Medical Center and an Associate Professor of Emergency Medicine at the University of Minnesota Medical School. He serves as the Associate Medical Director for Hennepin County Medical Services and Medical Director for Emergency Preparedness at HCMC. He is medical advisor to the Minneapolis/St. Paul Metropolitan Medical Response System. He also serves the Minnesota Department of Health as the Medical Director for the Office of Emergency Preparedness and Medical Director for Hospital Bioterrorism Preparedness. He is the founder and past chair of the Minneapolis/St. Paul Metropolitan Health Compact\, a 29-hospital mutual aid and planning group. The regional program was recognized with a $2.5 million competitive HHS preparedness grant in 2007. Hick traveled to Greece as part of a 15-member CDC/HHS team to assist with health care system preparations for the 2004 Summer Olympics. He continues to work with HHS and other agencies on issues of hospital surge capacity planning\, adjusted standards of care in disasters\, and preparedness for nuclear terrorism.\n\n  \n\nRebecca E. Gee\, MD\, is the Secretary of the Louisiana Department of Health\, the state’s largest agency with a budget of $14 billion\, and Gratis Assistant Professor at the LSU Schools of Public Health and Medicine. Her oversight responsibilities include public health and other direct service programs for citizens in needs such as behavioral health\, developmental disabilities\, aging and adult services\, emergency preparedness ad the Medicaid program. Her Medicaid expansion work resulted in an additiona 500\,000+ Louisiana residents being newly insured and the launch of a dashboard to measure access to health care services that has become a national model used in other states. She is an OB/GYN\, trained policy expert and previously served as the director of the Birth Outcomes Initiative\, where she led the charge to decrease infant mortality and prematurity statewide — an effort that in part led to a 25% reduction in infant mortality\, an 85% drop in elective deliveries before 39 weeks and a 10% drop in NICU admissions.\n\n  \n\nJeffrey Kahn\, PhD\, MD\, is the is the Andreas C. Dracopoulos Director of the Johns Hopkins Berman Institute of Bioethics and the inaugural Robert Henry Levi and Ryda Hecht Levi Professor of Bioethics and Public Policy. He is also Professor in the Department of Health Policy and Management of the Johns Hopkins Bloomberg School of Public Health. He works in a variety of areas of bioethics\, exploring the intersection of ethics and health/science policy. Kahn has served on numerous state and federal advisory panels and is currently chair of National Academies of Sciences\, Engineering\, and Medicine’s Board on Health Sciences Policy\, and has previously chaired its committee on the Use of Chimpanzees in Biomedical and Behavioral Research; the committee on Ethics Principles and Guidelines for Health Standards for Long Duration and Exploration Spaceflights; and a committee on the Ethical\, Social\, and Policy Considerations of Mitochondrial Replacement Techniques. He also formerly served as a member of the National Institutes of Health Recombinant DNA Advisory Committee. In addition to committee leadership and membership\, he is an elected member of the National Academy of Medicine and an elected Fellow of The Hastings Center. He was also the founding president of the Association of Bioethics Program Directors. He is a co-principal investigator with Berman Institute faculty member Gail Geller\, ScD\, MHS\, on GUIDE: Genomic Uses in Infectious Disease and Epidemics\, an NIH-funded project to study the largely unexplored ethical\, legal and social implications of genomics as applied to infectious disease.\n\n  \n\nLawrence “Larry” O. Gostin\, JD\, directs the O’Neill Institute for National and Global Health Law and is the founding O’Neil Chair in Global Health Law at Georgetown University. He served as associate dean for research at Georgetown Law from 2004-2008 and is professor of medicine at Georgetown University and professor of public health at Johns Hopkins University. He is director of the World Health Organization Collaborating Center on National and Global Health Law. Among his appointed posts at WHO\, he served on the Director-General’s Advisory Committee on Reforming the World Health Organization\, is on the International Health Regulations Roster of Experts and has served on many WHO expert advisory committees including on the Pandemic Influenza Preparedness Framework and on the WHO/Global Fund Blue Ribbon Expert Panel: The Equitable Access Initiative to develop a global health equity framework. He co-chairs the Lancet Commission on Global Health Law. He served on two global commissions to report on the lessons learned from the 2015 West African Ebola epidemic and was senior advisor to the United Nations Secretary General’s post-Ebola Commission. Gostin also served on the drafting team for the G-17 Summit in Tokyo in 2016\, focusing on global health security and universal health coverage.
URL:https://globalbiodefense.com/event/apha-and-national-academy-of-medicine-webinar-crisis-standards-of-care-during-covid-19/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20200415T123000
DTEND;TZID=America/Los_Angeles:20200415T140000
DTSTAMP:20240623T231227Z
CREATED:20200408T174031Z
LAST-MODIFIED:20240623T231227Z
UID:42787-1586953800-1586959200@globalbiodefense.com
SUMMARY:Protecting Older Adults from the Harms of Social Isolation and Providing a Continuum of Care During COVID-19
DESCRIPTION:Join Trust for America’s Health (TFAH) on Wednesday\, April 15th for the webinar Protecting Against the Harms of Social Isolation During COVID-19. \nThe ongoing COVID-19 crisis presents unique challenges for the public health and aging sectors. While social distancing protects older adults who are at higher risk for complications from the virus\, the practice can exacerbate social isolation\, a longstanding issue for this population. \nAttendees will learn about the consequences of social isolation\, how the aging services sector has adapted its delivery models\, promising practices from the field and the importance of working with public health partners to address the needs of older adults.
URL:https://globalbiodefense.com/event/protecting-older-adults-from-the-harms-of-social-isolation-and-providing-a-continuum-of-care-during-covid-19/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200409
DTEND;VALUE=DATE:20200410
DTSTAMP:20200211T235015Z
CREATED:20200211T234714Z
LAST-MODIFIED:20200211T235015Z
UID:39309-1586390400-1586476799@globalbiodefense.com
SUMMARY:Deadline for NIAID BAA Proposals: Advanced Development of Diagnostics for Biothreats and EID
DESCRIPTION:HHS-NIH-NIAID-BAA2020-1\nResearch Area 005: Advanced Development of Diagnostics for Biothreats and Emerging Infectious Diseases\n\nSupports advancing the development of novel\, rapid sample-to-answer candidate diagnostic products that will address biodefense and pandemic preparedness.\nNumber of Awards/Total Costs: NIAID estimates that one or more awards may be issued for this Research Area for a total cost of up to $2 million for the non-severable base work across all contracts (direct and indirect costs combined).\nDue Date: April 9\, 2020\, by 3 p.m. Eastern Time\n\nLearn more about this BAA in Funding News. \nGlobal Biodefense provides this information as a courtesy. Information is subject to change. Please check the funding opportunity sponsor website to verify the most current status.
URL:https://globalbiodefense.com/event/deadline-for-niaid-baa-proposals/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200409
DTEND;VALUE=DATE:20200410
DTSTAMP:20200211T234620Z
CREATED:20200211T234423Z
LAST-MODIFIED:20200211T234620Z
UID:39307-1586390400-1586476799@globalbiodefense.com
SUMMARY:Deadline for NIAID BAA Proposals: Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases
DESCRIPTION:HHS-NIH-NIAID-BAA2020-1\nResearch Area 003: Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases\nSupports development of vaccines 1) to address antibiotic resistant gram-negative bacteria focusing on but not limited to Burkholderia spp.\, Pseudomonas aeruginosa\, Francisella tularensis\, Yersinia pestis\, and E. coli\, and 2) for emerging viruses and pandemic preparedness that includes but is not limited to alphaviruses (e.g.\, Eastern Equine Encephalitis) and bunyaviruses (e.g.\, Rift Valley Fever Virus). \nDue Date: April 9\, 2020\, by 3 p.m. Eastern Time \nLearn more about this opportunity in here. \nGlobal Biodefense provides this information as a courtesy. Information is subject to change. Please check the funding opportunity sponsor website to verify the most current status.
URL:https://globalbiodefense.com/event/deadline-for-niaid-baa-proposals-advanced-development-of-vaccine-candidates-for-biodefense-and-emerging-infectious-diseases/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200409
DTEND;VALUE=DATE:20200410
DTSTAMP:20200211T233920Z
CREATED:20200211T233539Z
LAST-MODIFIED:20200211T233920Z
UID:39302-1586390400-1586476799@globalbiodefense.com
SUMMARY:Deadline for NIAID BAA Proposals: Therapeutic Products for Biodefense\, AMR Infections\, and Emerging Infectious Diseases
DESCRIPTION:HHS-NIH-NIAID-BAA2020-1\nResearch Area 004: Development of Therapeutic Products for Biodefense\, Anti-Microbial Resistant (AMR) Infections\, and Emerging Infectious Diseases\nSupports development of promising new therapeutics to address infections caused by NIAID Category A\, B\, and C priority pathogens and select bacterial and fungal infections identified in CDC’s report Antibiotic Resistance Threats in the United States 2019 \, including optimization\, preclinical (investigational new drug-enabling)\, and clinical trials that include Phase I and Phase II studies. \nDue Date: April 9\, 2020\, by 3 p.m. Eastern Time \nRead more on this opportunity in Funding News. \n  \nGlobal Biodefense provides this information as a courtesy. Information is subject to change. Please check the funding opportunity sponsor website to verify the most current status.
URL:https://globalbiodefense.com/event/deadline-for-niaid-baa-proposals-therapeutic-products-for-biodefense-amr-infections-and-emerging-infectious-diseases/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200409
DTEND;VALUE=DATE:20200410
DTSTAMP:20200211T233435Z
CREATED:20200211T233017Z
LAST-MODIFIED:20200211T233435Z
UID:39300-1586390400-1586476799@globalbiodefense.com
SUMMARY:Deadline for NIAID BAA Proposals: Development of Radiation/Nuclear Medical Countermeasures
DESCRIPTION:Research Area 001: Development of Radiation/Nuclear Medical Countermeasures (MCMs) HHS-NIH-NIAID-BAA2020-1\nThis research topic call for proposals is part of the 2020 NIAID Omnibus Broad Agency Announcement. \nIt supports the development of safe and effective MCMs to mitigate and/or treat tissue injuries resulting from exposure to ionizing radiation from a radiological or nuclear incident\, thereby leading to a reduction in radiation-associated morbidities and mortalities. \nDue Date: April 9\, 2020\, by 3 p.m. Eastern Time \nRead more about this opportunity in Funding News.
URL:https://globalbiodefense.com/event/deadline-for-niaid-baa-proposals-development-of-radiation-nuclear-medical-countermeasures/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200408T140000
DTEND;TZID=America/New_York:20200408T153000
DTSTAMP:20200402T171318Z
CREATED:20200402T170907Z
LAST-MODIFIED:20200402T171318Z
UID:42524-1586354400-1586359800@globalbiodefense.com
SUMMARY:NASEM Webinar: The Supply Chain and COVID-19
DESCRIPTION:COVID-19 has had a profound impact on supply chains for many different critical products worldwide. The pandemic has created major changes in freight flows and has challenged the ability to deliver both medical supplies and food. \nThe National Academies’ Transportation Research Board (TRB) is hosting a webinar on Wednesday\, April 8\, 2020\, from 2:00 to 3:30 PM Eastern that will explore the impacts of COVID-19 on the supply chain and logistics industries. Presenters will discuss lessons learned from past freight transportation and supply chain disruptions\, identify research that has been done to address resilience in the supply chain\, describe how to mitigate the economic impacts of these disruptions\, and provide commentary on current supply chain disruptions due to COVID-19. The webinar is free to attend\, but registration is required. You can follow the conversation on Twitter by using #COVID19 and #TRBwebinar. \nWebinar Participants\n• Moderated by: Mike Meyer\, WSP\, Principal Investigator for NCFRP Research Report 39: Freight Transportation Resilience in Response to Supply Chain Disruptions\n• Paul Bingham\, IHS Markit\, expert in supply chain logistics\, freight transportation\, and transportation economics\n• Anne Strauss-Wieder\, North Jersey Transportation Planning Authority\, expert in supply chain and freight movement\, transportation policy\, and maritime transportation \nWebinar Outline \n1. How the supply chain industry has responded to past disruptions\n2. Lessons learned from past disruptions and best practices for a resilient supply chain\n3. How supply chain and logistics managers can respond to disruptions from COVID-19\n4. Question and answer session\nThe first 60 minutes of the webinar will be for presentations and the final 30 minutes will be reserved for audience questions. \nResources about supply chain and logistics from TRB: \n\nNCFRP Research Report 39: Freight Transportation Resilience in Response to Supply Chain Disruptions\nE-Circular E-C259: International Transportation and Economic Development Conference 2018\nTR News article: Supply Chain Business Continuity\nTR News article: Aviation’s Evolving Role in a Changing Climate\nTRB Director Neil Pedersen’s message regarding COVID-19
URL:https://globalbiodefense.com/event/nasem-webinar-the-supply-chain-and-covid-19/
LOCATION:Virtual-Webcast
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200406
DTEND;VALUE=DATE:20200407
DTSTAMP:20200211T235602Z
CREATED:20200211T235220Z
LAST-MODIFIED:20200211T235602Z
UID:39312-1586131200-1586217599@globalbiodefense.com
SUMMARY:Proposals Due: Influenza Data Processing and Outreach
DESCRIPTION:If your small business has strong experience with scientific data processing and outreach\, consider sending a contract proposal to establish an Influenza Data Processing and Communication Center (iDPCC). \nThis solicitation recompetes and renames the current influenza DPCC contract to support NIAID’s Centers of Excellence for Influenza Research and Response (CEIRR) network. \nSubmit your proposal by April 6\, 2020. If you have any questions\, send them to the contracting officer listed in the solicitation no later than March 4\, 2020. \nLearn more about this funding opportunity in Funding News \n  \nGlobal Biodefense provides this information as a courtesy. Information is subject to change. Please check the funding opportunity sponsor website to verify the most current status. \n 
URL:https://globalbiodefense.com/event/proposals-due-influenza-data-processing-and-outreach/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200330
DTEND;VALUE=DATE:20200401
DTSTAMP:20200313T155419Z
CREATED:20200304T182006Z
LAST-MODIFIED:20200313T155419Z
UID:40666-1585526400-1585699199@globalbiodefense.com
SUMMARY:SMi’s 22nd Annual Superbugs & Superdrugs - Remote Access Conference
DESCRIPTION:Due to ongoing concerns over COVID-19 this conference is now available with remote access only \nSMi’s 22nd Annual Superbugs & Superdrugs 2020 Conference will be held  30-31 March 2020. \nA Focus on Non-traditional Approaches in the Fight against Antimicrobial Resistance \nSponsored by Scynexis \nCO-CHAIRS FOR 2020: Cara Cassino\, Chief Medical Officer\, Contrafect & Michael Dawson\, Director\, Mike Dawson Antimicrobial Research Consultancy \nAs one of the most impactful pharmaceuticals for maintaining public health\, antibiotics have been around since early 20th century and have since shown a need for significant progress in recent years. This is mainly due to its broad and indiscriminate use which has slowly given birth to multi- to extensively-drug resistant bacteria rendering our current last-resort antibiotic arsenal\, including colistin\, carbapenems\, 3rd and 4th generation cephalosporins\, useless. \nThis year’s event aims to showcase a suite of sessions focused on novel drugs and approaches\, particularly highlighting non-traditional and traditional therapies that provide an innovative means to spearhead the issue. The conference will also place significant emphasis on the much-needed support for innovative approaches such as sessions tackling the funding and support and the regulation that provides guidance towards the goal of ameliorating the continued rise of anti-microbial resistance AMR. \nIt is crucial to bring industry leaders together to discuss the strategies in place that reduce AMR\, evaluate the role pharmaceutical companies and funding bodies play in reducing AMR\, learn about new diagnostics approaches to identify AMR and consider novel candidates and alternatives to anti-microbials. Join us in March 2020\, along with leaders from the pharmaceutical industry\, academia\, regulatory and funding bodies\, and public-private partnerships to discuss the way forward. \nEvent Hashtag: #SMiBugs \nFEATURED SPEAKERS FOR 2020: \n\nYuri Gleba\, Professor\, Founder\, Nomad Bioscience\nMark Albrecht\, Branch Chief\, Antibacterials program\, BARDA/HHS\nPaul Finn\, CEO\, Oxford Drug Design\nCara Cassino\, Chief Medical Officer\, Contrafect\nMartin Everett\, CSO\, Antabio\nSamareh Lajaunias\, Director\, Combioxin SA\nFrancois Moreau\, Scientific Director\, Mutabilis\nEmma Leire\, Microbiology Lead\, Centauri Therapeutics\nLorenzo Corsini\, Co-Founder/CEO/R&D\, Phagomed\nStephen Barat\, VP\, Preclinical Research and Early Development\, Scynexis\nColm Leonard\, Consultant Clinical Adviser/Consultant Thoracic Physician/Honorary Pro\n\nWHATS ON THE AGENDA FOR 2020? \n\nDiscuss the new classes of non-antibiotic antibacterial proteins: Colicins and Colicin-like Bacteriocins from Nomad Bioscience\nGain valuable insight towards fighting severe and resistant infections through neutralising bacterial virulence effectors from Combioxin\nExamine a UK project looking at novel value assessment and reimbursement for novel antimicrobials from NICE/Manchester University NHS Foundation Trust\nExplore direct lytic agents (DLAs) and their potential as a successful disruptive anti-infective technology with Contrafect\nEvaluate the utility of machine learning and AI in antibiotic drug discovery with Oxford Drug Design\n\nGlobal Biodefense is an official media partner of Superbugs & Superdrugs 2020.
URL:https://globalbiodefense.com/event/smis-22nd-annual-superbugs-superdrugs-conference/
LOCATION:Holiday Inn Kensington Forum\, 97 Cromwell Rd\, London\, SW7 4DN\, United Kingdom
CATEGORIES:Conference
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/03/superbugs-superdrugs-2020-smi-group.jpg
END:VEVENT
END:VCALENDAR